These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 15717310)

  • 41. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia.
    Müller I; Urban K; Pantel K; Schwarzenbach H
    Ann N Y Acad Sci; 2006 Sep; 1075():222-9. PubMed ID: 17108215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Frequent loss of heterozygosity on chromosome 4 in human hepatocellular carcinoma].
    Li X; Ding M; Lai B
    Zhonghua Yi Xue Za Zhi; 2001 Jan; 81(1):37-40. PubMed ID: 11798850
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
    Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and characterization of proximal 6q deletions in prostate cancer.
    Cooney KA; Wetzel JC; Consolino CM; Wojno KJ
    Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.
    Cetin E; Cengiz B; Gunduz E; Gunduz M; Nagatsuka H; Bekir-Beder L; Fukushima K; Pehlivan D; N MO; Nishizaki K; Shimizu K; Nagai N
    Neoplasma; 2008; 55(4):299-304. PubMed ID: 18505340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer.
    Wu YQ; Chen H; Rubin MA; Wojno KJ; Cooney KA
    Cancer Res; 2001 Dec; 61(24):8651-3. PubMed ID: 11751379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Analysis of loss of heterozygosity on chromosome 8 in human prostate carcinoma and high grade prostatic intraepithelial neoplasia].
    Wang Z; Lai FM
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):26-8, 31. PubMed ID: 14979203
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
    Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
    Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer.
    Cengiz B; Gunduz M; Nagatsuka H; Beder L; Gunduz E; Tamamura R; Mahmut N; Fukushima K; Ali MA; Naomoto Y; Shimizu K; Nagai N
    Oral Oncol; 2007 Mar; 43(3):241-7. PubMed ID: 16857411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
    Cairns P; Okami K; Halachmi S; Halachmi N; Esteller M; Herman JG; Jen J; Isaacs WB; Bova GS; Sidransky D
    Cancer Res; 1997 Nov; 57(22):4997-5000. PubMed ID: 9371490
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
    Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
    Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis.
    Piao Z; Lee KS; Kim H; Perucho M; Malkhosyan S
    Genes Chromosomes Cancer; 2001 Feb; 30(2):113-22. PubMed ID: 11135428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers.
    Ohgaki K; Iida A; Kasumi F; Sakamoto G; Akimoto M; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Nov; 23(3):244-7. PubMed ID: 9790505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Loss of heterozygosity fine mapping of chromosome 17p13 in transitional cell carcinoma of human urinary bladder].
    Zheng S; Zhang J; Di X; Xiao Z; Wang D; Li C; He Z; Han N; Guo S; Cheng S; Gao Y
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):161-3. PubMed ID: 11953150
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Refined mapping of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer].
    Xu SF; Li DP; Peng ZH
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):413-7. PubMed ID: 19024513
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deletion mapping on the short arm of chromosome 1 in Merkel cell carcinoma.
    Leonard JH; Cook AL; Nancarrow D; Hayward N; Van Gele M; Van Roy N; Speleman F
    Cancer Detect Prev; 2000; 24(6):620-7. PubMed ID: 11198276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.